{"title":"A fuzzy generalized predictive controller to optimal drug dosage therapy of mathematical modeling of HIV","authors":"Arezoo Vafamand, A. Fatehi, S. Oliaee","doi":"10.22111/IJFS.2021.6256","DOIUrl":null,"url":null,"abstract":"This paper proposes a fuzzy-GPC based on a mathematical model of human immunodeficiency virus (HIV) to determine the drug dosage and control the progression of the illness. For this purpose, a Takagi-Sugeno (TS) fuzzy model is generated to identify the nonlinear behavior of HIV. The parameters of HIV are estimated by the least square error (LSE) estimation method. Moreover, three scenarios are proposed to control HIV. In scenario 1, according to TS fuzzy model, generalized Predictive Control (GPC) is designed for a daily base drug therapy. Scenario 2 and 3 are more practical. In scenario 2, since the biological behavior of patients are different, the variation in the patients biology is taken into account by generating data according to a group of patients with varying parameters in their mathematical model. In senario3, since daily diagnosis of patient’s health is costly, it is assumed that a patient information is available every month, and drug dosage is determined each month. As a result of which, the sample time of the measurement increases to 30 make it a multi-rate system. The result shows that the TS fuzzy models the mathematical model of HIV very well, and in all scenarios, the proposed controller has a good performance and the number of healthy cells are controlled in acceptable amount.","PeriodicalId":54920,"journal":{"name":"Iranian Journal of Fuzzy Systems","volume":"20 1","pages":"69-85"},"PeriodicalIF":1.9000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Fuzzy Systems","FirstCategoryId":"100","ListUrlMain":"https://doi.org/10.22111/IJFS.2021.6256","RegionNum":4,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATHEMATICS","Score":null,"Total":0}
引用次数: 0
Abstract
This paper proposes a fuzzy-GPC based on a mathematical model of human immunodeficiency virus (HIV) to determine the drug dosage and control the progression of the illness. For this purpose, a Takagi-Sugeno (TS) fuzzy model is generated to identify the nonlinear behavior of HIV. The parameters of HIV are estimated by the least square error (LSE) estimation method. Moreover, three scenarios are proposed to control HIV. In scenario 1, according to TS fuzzy model, generalized Predictive Control (GPC) is designed for a daily base drug therapy. Scenario 2 and 3 are more practical. In scenario 2, since the biological behavior of patients are different, the variation in the patients biology is taken into account by generating data according to a group of patients with varying parameters in their mathematical model. In senario3, since daily diagnosis of patient’s health is costly, it is assumed that a patient information is available every month, and drug dosage is determined each month. As a result of which, the sample time of the measurement increases to 30 make it a multi-rate system. The result shows that the TS fuzzy models the mathematical model of HIV very well, and in all scenarios, the proposed controller has a good performance and the number of healthy cells are controlled in acceptable amount.
期刊介绍:
The two-monthly Iranian Journal of Fuzzy Systems (IJFS) aims to provide an international forum for refereed original research works in the theory and applications of fuzzy sets and systems in the areas of foundations, pure mathematics, artificial intelligence, control, robotics, data analysis, data mining, decision making, finance and management, information systems, operations research, pattern recognition and image processing, soft computing and uncertainty modeling.
Manuscripts submitted to the IJFS must be original unpublished work and should not be in consideration for publication elsewhere.